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Background: Traditional quantitative analysis of cartilage with MRI averages measurements (eg, thickness) across regions-
of-interest (ROIs) which may reduce responsiveness.
Purpose: To validate and describe clinical application of a semiautomated surface-based method for analyzing cartilage
relaxation times (“composition”) and morphology on MRI, 3D cartilage surface mapping (3D-CaSM).
Study Type: Validation study in cadaveric knees and prospective observational (cohort) study in human participants.
Population: Four cadaveric knees and 14 participants aged 40–60 with mild–moderate knee osteoarthritis (OA) and 6 age-
matched healthy volunteers, imaged at baseline, 1, and 6 months.
Field Strength/Sequence: 3D spoiled gradient echo, T1rho/T2 magnetization-prepared 3D fast spin echo for mapping of
T1rho/T2 relaxation times and delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using variable flip angle T1 relax-
ation time mapping at 3T.
Assessment: 3D-CaSM was validated against high-resolution peripheral quantitative computed tomography (HRpQCT) in
cadaveric knees, with comparison to expert manual segmentation. The clinical study assessed test–retest repeatability and
sensitivity to change over 6 months for cartilage thickness and relaxation times.
Statistical Tests: Bland–Altman analysis was performed for the validation study and evaluation of test–retest repeatability.
Six-month changes were assessed via calculation of the percentage of each cartilage surface affected by areas of signifi-
cant change (%SC), defined using thresholds based on area and smallest detectable difference (SDD).
Results: Bias and precision (0.06  0.25 mm) of 3D-CaSM against reference HRpQCT data were comparable to expert
manual segmentation (−0.13  0.26 mm). 3D-CaSM demonstrated significant (>SDD) 6-month changes in cartilage thick-
ness and relaxation times in both OA participants and healthy controls. The parameter demonstrating the greatest
6-month change was T2 relaxation time (OA median %SC [IQR] = 8.8% [5.5 to 12.6]).
Data Conclusion: This study demonstrates the construct validity and potential clinical utility of 3D-CaSM, which may offer
advantages to conventional ROI-based methods.
Level of Evidence: 2.
Technical Efficacy Stage: 2.
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CARTILAGE BREAKDOWN is a hallmark of osteoar-thritis (OA), and its prevention remains a therapeutic
target.1 Therefore, the development and optimization of
quantitative imaging biomarkers (QIBs) of cartilage health is
desirable.
Quantification of cartilage morphology (volume and
thickness) and relaxation times (eg, T1rho, T2, T1) using
magnetic resonance imaging (MRI) is well established and
has been implemented in several clinical trials and observa-
tional studies.2–4 Analysis pipelines usually require expert
manual segmentation of articular cartilage. While this can be
accurate and reliable, it suffers from three main drawbacks.
First, it is time-consuming and represents a considerable
resource burden for researchers. Second, even in expert hands
manual segmentation is, in general, less reproducible and sen-
sitive to change than automated or semiautomated
approaches, although this will vary depending on the exact
algorithm/method used.5,6 Third, cartilage measurements
tend to be averaged over large regions of interest (ROIs).
While these averaged measurements may be attractively sim-
ple, such approaches limit responsiveness and average out
potentially important focal changes.7 It has been shown that
manual segmentation-based approaches for cartilage morphol-
ogy are unlikely to be sufficiently responsive in clinical studies
with 6 months or less follow-up.8,9
These drawbacks limit the utility of cartilage QIBs in
clinical trials, particularly in early-phase clinical trials where
sample sizes are small and follow-up periods are short. How-
ever, with the shift towards biomarker-rich experimental med-
icine study designs, there is increasing interest in the
potential utility of imaging biomarkers, including the ability
to demonstrate early proof-of-concept.10
Improved utility in this setting requires improved
responsiveness. This may be achieved by approaches that bet-
ter reflect the spatial distribution of changes in cartilage and
which include automated or semiautomated segmentation
pipelines. Here we propose a method that meets these
criteria, which we term 3D cartilage surface mapping (3D-
CaSM). This is a modification of the previously described
methods of cortical bone mapping (CBM) and joint space
mapping (JSM). CBM has been validated and used exten-
sively for the measurement of cortical bone thickness in oste-
oporosis.11,12 JSM has been validated for the 3D
measurement of joint space width from clinical computed
tomography (CT) data.13 The underlying measurement algo-
rithm can overcome inherent inaccuracies in measurement of
thin plate-like structures at clinical imaging resolutions related
to slice thickness and the imaging system’s point spread func-
tion via model-based deconvolution of the imaging data.14,15
Therefore, the purpose of this study was to describe the
validation and initial clinical application of 3D-CaSM, a
novel surface-based semiautomatic analysis method for the
assessment of cartilage on MRI.
Materials and Methods
Study Design
The described work consists of a validation study in cadavers (referred to
as the validation study) and an in vivo study demonstrating the clinical
application of this method (referred to as the clinical study). The valida-
tion study compared cartilage thickness measurements performed on
cadaveric knees between MRI and the reference method of high-
resolution peripheral quantitative computed tomography (HRpQCT).
The clinical study assessed the interobserver reproducibility and test–
retest repeatability of 3D-CaSM and sensitivity to change over 6 months
in participants with knee OA and age-matched healthy volunteers.
Cadaveric studies were approved by the University of Cam-
bridge Human Biology Research Ethics Committee, with all partici-
pants having given antemortem written consent for postmortem use
of samples in research. Clinical studies were approved by the Local
Research Ethics Committee, and written informed consent was pro-
vided by all participants.
Validation Study: Participants
Four embalmed (not frozen) human cadaveric knees (two female,
aged 81–89 years old) were obtained from the University of Cam-
bridge Human Anatomy Centre. Specimens consisted of intact artic-
ulated knee joints from distal femoral diaphysis to proximal tibial
diaphysis and included all periarticular soft tissues. Details of the
embalming process are provided in the Supplementary Materials.
Validation Study: Image Acquisition
Intact cadaveric knees underwent MRI on a clinical 3T system
(MR 750; GE Healthcare, Waukesha, WI) using an 8-channel trans-
mit/receive knee coil (Invivo, Gainesville, FL). A 3D fat-suppressed
spoiled gradient echo (3D SPGR) sequence was performed aiming
to optimize contrast resolution between articular cartilage, adjacent
bone, and synovial fluid and to maximize spatial resolution within a
clinically feasible acquisition time. Imaging parameters were as fol-
lows: field of view, 150 × 150 × 140 mm3; matrix 512 × 380
(interpolated to 512 × 512) with in-plane spatial resolution
0.3 × 0.3 mm; slice thickness 1 mm; flip angle 25; repetition time
26 msec; echo time 6.8 msec; acquisition time ~7 minutes.
Anatomical dissection was performed following MRI to allow
disarticulation of the knees into individual bones. The periarticular
soft tissues, ligaments, capsule, and menisci were removed to leave
the bones with cartilage surfaces exposed. Dissection was necessary
because 1) the contrast resolution for cartilage on CT in intact joints
is poor due to the presence of adjacent structures with similar atten-
uation coefficients, and 2) intact knees would not fit inside the bore
of the HRpQCT scanner. To prevent desiccation, all specimens
remained stored in embalming fluid and kept in a refrigerated facility
(between 10 and 12 C) when not being imaged.
Disarticulated femurs and tibias were then imaged with
HRpQCT (Xtreme CT; Scanco Medical, Brüttisellen, Switzerland)
with peak voltage of 59.4 kV, tube current of 0.18 mAs. Images
were acquired with an isotropic voxel size of 0.082 mm, providing a
higher spatial resolution than achievable using clinical MRI (voxel
size 0.3 × 0.3 × 1 mm). Disarticulated specimens were mounted in
an acrylic holder and secured using padding material prior to scan-
ning, ensuring that an air–cartilage interface was maintained across
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the surface and that the articular cartilage was not in contact with
the holder at any point.
Validation Study: Image Analysis
3D SPGR images were imported in Digital Imaging and Communica-
tions in Medicine (DICOM) format into Stradwin v. 5.4a (University
of Cambridge Department of Engineering, Cambridge, UK, now freely
available as ‘StradView’ at http://mi.eng.cam.ac.uk/Main/StradView/)
for 3D-CaSM. The initial 3D-CaSM analysis process is summarized in
Fig. 1 with a full description in the Supplementary Material. This
results in ~6000 thickness measurements for a single knee, together
with accurately located inner and outer cartilage surfaces.
Full manual cartilage segmentation was performed by a mus-
culoskeletal radiologist with 6 years’ experience in OA research
(J.M.). Segmentation was done using every second slice (ie, every
2 mm). This takes ~3–4 hours for a single knee. Manual thickness
values were obtained by taking the distance between the intersec-
tions of the outer and inner surface on the manual segmentation
with an automatically generated vector normal to each vertex on the
cartilage patches generated by 3D-CaSM for that knee, ensuring spa-
tial correspondence of 3D-CaSM and manual thickness values.
Detailed methodology for the generation of HRpQCT mea-
surements is provided in the Supplementary Material. In brief, the
process resulted in a set of spatially corresponding HRpQCT and
MRI thickness measurements.
Validation Study: Statistical Analysis
The thickness value at each vertex on each cadaveric MRI surface
was compared to the thickness value at the identical location on the
corresponding HRpQCT surface for both 3D-CaSM and manual
segmentation. Bland–Altman analysis was performed to calculate the
mean bias, 95% limits of agreement (LOA), and repeatability coeffi-
cients (RC) for MRI compared to HRpQCT thickness measure-
ments (Supplementary Methods). For the purposes of this study, the
LOA is the interval [–RC, RC] where the difference between two
measurements under repeatability conditions for a randomly selected
vertex is expected to be 95% of the time.16
Data were analyzed separately for each cartilage surface and also
with data combined from all surfaces. By performing appropriate spa-
tial normalization (surface-to-surface combined similarity and thin-plate
spline registration performed in wxRegSurf v. 18; University of Cam-
bridge Department of Engineering, Cambridge, UK, freely available at
http://mi.eng.cam.ac.uk/~ahg/wxRegSurf/), the spatial distribution of
MRI-HRpQCT error values across all cadaveric subjects could be dis-
played on representative canonical (template) surfaces.
Clinical Study: Participants
Fourteen participants with mild–moderate knee OA and six healthy
volunteers (HV) were imaged at baseline and 6 months. One-to-one
matching of OA and HV participants was not performed as it was
felt that the HV population were likely to be more homogeneous in
terms of their cartilage measurements. Fifteen of these participants
FIGURE 1: Outline of initial steps in 3D-CaSM pipeline, from image acquisition to thickness measurement. The surface generated in
steps 2–4 is only used as a guide for cartilage location, and therefore does not need to be highly accurately segmented. Step
6 results in the generation of accurate inner and outer cartilage surfaces between which the thickness measurements were made.
Femur used for demonstration purposes; 3D-CaSM was also performed for tibial cartilage surfaces.
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(nine OA, six HV) were also imaged at 1 month for assessment
of test–retest repeatability. The main inclusion criteria for both
groups were age 40–60 years, body mass index ≤35 kg/m2, and
the imaged knee able to fit within the knee MRI coil (diameter
~18 cm). Additional inclusion criteria for OA participants were a
clinical diagnosis of OA per American College of Rheumatology
criteria and medial compartment predominant disease with a
Kellgren–Lawrence grade of 2–3 as assessed on a posteroanterior
fixed flexion knee radiograph using a positioning device
(SynaFlexer; BioClinica, Newtown, PA).17–19 Main exclusion
criteria for both groups were a history of previous ipsilateral
lower limb fracture or surgery (including arthroscopy), history of
significant soft-tissue knee injury (defined as being unable to
walk normally for more than 1 week), history of metabolic bone
disease or inflammatory arthritis or contraindication to MRI. We
excluded any MRI dataset that demonstrated excessive artifact
precluding quantitative assessment as judged by a musculoskele-
tal radiologist. The most common reasons for exclusion were
phase wrap (most commonly in the medial–lateral direction for
3D volumetric acquisitions) and excessive motion artifact. At
each study visit participants completed the Knee Injury and
Osteoarthritis Outcome Score (KOOS) to assess symptoms and
had their body mass index (BMI) recorded.20
Clinical Study: Image Acquisition
All participants underwent MRI on the same 3T platform and
using the same knee coil as used for cadaveric imaging. The symp-
tomatic knee was imaged in OA participants. For HV participants
a knee was selected using a random number generator. The same
3D SPGR sequence as used for cadaveric knees with identical
parameters was also used for assessment of cartilage morphology.
We also performed quantitative T1rho (longitudinal relaxation in
the presence of a radiofrequency field) and T2 (transversal relaxa-
tion) relaxation time mapping using T1rho/T2 magnetization pre-
pared pseudosteady-state 3D fast spin echo (FSE) sequences, with
imaging after a period of unloading of at least 45 minutes.21 We
also performed delayed gadolinium-enhanced MRI of cartilage
(dGEMRIC) by administering intravenous gadolinium-based con-
trast agent (GBCA; Dotarem; Guerbet, Paris, France) at a dose of
0.2 mmol/kg at the end of the first imaging session. After leaving
the scanner room, participants cycled for 10 minutes on a station-
ary cycle to promote GBCA penetration into the knee joint
followed by an 80-minute rest period to allow distribution of
GBCA within the cartilage. Participants then returned for a second
imaging session consisting of quantitative T1 (longitudinal relaxa-
tion) relaxation time mapping using a variable flip angle approach.
Sequence parameters for all MRI sequences are provided in
Table 1. A detailed description of the correlation between these
relaxation time methods with cartilage health/disease states is out-
side the scope of this article and can be found elsewhere.22,23 In
brief, T1rho relaxation time is sensitive to alterations in the proteo-
glycan content, collagen orientation, and water content of cartilage,
T2 relaxation time is sensitive to alterations in collagen orientation
and water content of cartilage, and dGEMRIC is sensitive to alter-
ations in glycosaminoglycan content, although the reported correla-
tion between these methods and individual tissue components is
variable.24–26
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Clinical Study: Image Analysis
Thickness measurement with 3D-CaSM was done using the 3D
SPGR sequence following the process described for the validation
study. For analysis of cartilage relaxation times, parameter maps for
T1rho and T2 relaxation times and dGEMRIC were created from
source images registered to the 3D SPGR sequence. Rigid registra-
tion of source to 3D SPGR images was performed using the elastix
registration tool without interpolation of the source data.27 The
femur and tibia were registered separately using masking to allow for
different degrees of knee flexion between sequences and improve reg-
istration accuracy, as described previously.28 Parameter maps were
then generated for each relaxation time measurement by fitting the
observed signal for each pixel to the appropriate equation
(Supplementary Table 1). Goodness-of-fit statistics were extracted
for each pixel, and pixels with poor fits (operationally defined as
R2 < 0.8) or implausible values (Supplementary Table 1) were
excluded from subsequent analysis. In practice, very few (<1%) carti-
lage voxels were excluded.
Inner and outer cartilage surfaces generated by the thickness
measurement process were imported into the registered parameter
maps. Relaxation time parameters at each vertex on the cartilage sur-
face were then measured by sampling the data along the surface nor-
mal connecting each vertex on the inner surface to its correspondent
on the outer surface and taking the mean value
(Supplementary Fig. 2).
Cartilage surfaces from each timepoint from each participant
were spatially normalized to a canonical (template) surface using a
combined similarity and thin-plate-spline transformation. All surface
data from all participants could then be mapped to the same tem-
plate surface to facilitate further spatially-corresponded analysis.
Two independent observers (J.M. and T.T., a musculoskeletal
radiologist with 10 years’ experience) performed 3D-CaSM on 10 ran-
domly selected knees for assessment of interobserver reproducibility.
Both observers also performed manual segmentation of the femoral
and tibial cartilage to allow comparison of interobserver reproducibility
between 3D-CaSM and manual segmentation. Manual thickness
values were obtained as described for the validation study.
Clinical Study: Statistical Analysis
In the presentation of 3D-CaSM results, we draw the distinction
between vertexwise analyses where the values from all surface vertices
(total ~6000 per participant) are used, and surfacewise analyses where
a surface-averaged value is used.
For analysis of interobserver reproducibility, we performed
surfacewise and vertexwise comparison between the two observers’
measurements and calculated root mean square coefficients of variation
(RMSCVs) for each cartilage surface. The RMSCV is calculated as:
RMSCV =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Pn
i = 1
σ
μi
 2
n
vuuut ð1Þ
where σi is the standard deviation of two measurements for subject
i, and μi is the mean of the two measurements.
For analysis of test–retest repeatability, we calculated
RMSCVs for surfacewise and vertexwise differences between
baseline and 1-month data. We determined vertexwise smallest
detectable differences (SDD) for each surface-parameter combina-
tion via Bland–Altman analysis of test–retest data, taking the
Bland–Altman RC as the SDD (Supplementary Material). This
value represents the magnitude of change over time at a single ver-
tex that has a less than 5% chance of being due to measurement
error alone.29
For assessment of 6-month changes, we performed vertexwise
comparison between baseline and 6-month data. Because these data
were mapped to the same canonical surface, we could create individ-
ual “change surfaces” for each parameter at each timepoint. We then
defined regions of significant change by applying magnitude (change
greater than SDD calculated from the test–retest repeatability data
for that surface/parameter combination) and area (operationally
defined as occurring across a cluster covering at least 1% of the carti-
lage surface) thresholds to these change surfaces. The percentage of
each surface with areas of significant change was calculated and used
to define three summary metrics: %SCpos, %SCneg, %SCtotal,
defined respectively as the percentage of the surface with areas of
positive significant change (ie, parameter increase), negative signifi-
cant change (parameter decrease), and any significant change (regard-
less of sign). These metrics were compared between OA and HV
groups using descriptive statistics (medians and interquartile
ranges [IQR]).
As well as analyzing surface-based changes at an individual
level, the fact that all data were registered to a canonical surface per-
mits group-averaged analysis of vertexwise 6-month changes and per-
formance of statistical parametric mapping (SPM) to determine the
statistical significance of these changes. SPM was performed using
SurfStat (http://www.math.mcgill.ca/keith/surfstat/), a MatLab
(MathWorks, Natick, MA) toolbox for the statistical analysis of sur-
face data using linear models and random field theory. Linear mixed
models were constructed with timepoint as a fixed effect and subject
as a random effect. We considered a type 1 error rate of 10%
(P < 0.1) acceptable given the exploratory nature of this analysis.
Statistical analyses other than SPM were performed in R
v. 3.6.1.30
Results
Validation Study
Data from the four cadaveric specimens gave a total of
17,335 surface vertices for comparison between MRI and
HRpQCT. 3D-CaSM MRI thickness measurements demon-
strated a small positive mean bias (ie, a small systematic over-
estimation of cartilage thickness) when compared to
HRpQCT data, whereas manual MRI thickness measure-
ments demonstrated a small systematic underestimation
(Table 2). RCs were similar for both methods and were sub-
millimeter in all cases. The spatial distribution of MRI errors
was fairly uniform across the cartilage surfaces for both
methods with the exception of higher errors for 3D-CaSM at
the extreme medial aspect of the lateral tibial plateau, possibly
due to residual undissected ligamentous or meniscal tissue
confounding measurement at this site or partial volume
effects (Fig. 2).
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TABLE 2. Results of Bland–Altman Analyses for Comparison of MRI (3D-CaSM and Manual Segmentation) and
HRpQCT Thickness Values
Surface Method Mean bias MRI – HRpQCT (mm) 95% LOA (mm) RC (mm)
Femur 3D-CaSM 0.05 −0.40, 0.50 0.45
Manual −0.1 −0.58, 0.38 0.48
Medial tibia 3D-CaSM 0.15 −0.21, 0.52 0.37
Manual −0.17 −0.53, 0.19 0.36
Lateral tibia 3D-CaSM 0.11 −0.64, 0.85 0.74
Manual −0.25 −0.95, 0.45 0.70
All (combined) 3D-CaSM 0.06 −0.43, 0.56 0.50
Manual −0.13 −0.64,0.38 0.51
HRpQCT: high-resolution peripheral quantitative computed tomography; LOA: limits of agreement; RC: repeatability coefficient.
FIGURE 2: Bland–Altman plots assessing agreement between (a) 3D-CaSM and (b) manual segmentation with HRpQCT-derived
thickness measurements. Spatial distribution of average error for all cadaver knees is displayed on canonical surfaces for (c) 3D-
CaSM and (d) manual segmentation.
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Clinical Study
Clinical study participant characteristics at baseline are pro-
vided in Table 3. Two participants did not attend their
scheduled 6-month follow-up visit (one OA participant and
one HV) and were excluded from 6-month change analyses.
All 18 participants who completed baseline and 6-month
visits had analyzable datasets for thickness data. Seventeen
out of these 18 participants had analyzable datasets at both
TABLE 3. Participant Characteristics at Baseline
OA participants (n = 14) HV participants (n = 6)
Age (years)a 51 (49–56) 54 (54–57)
Sex (M:F) 8:6 2:4
BMI (kg/m2)a 29.3 (25.7–32.8) 29.3 (27.9–30.9)
Kellgren–Lawrence grade (2:3) 10:4 N/A
KOOS paina 54 (43–80) 100 (98–100)
KOOS symptomsa 57 (45–67) 96 (93–100)
KOOS ADLa 68 (49–86) 100 (100–100)
KOOS sport & recreationa 35 (16–55) 98 (91–100)
KOOS quality of lifea 25 (19–47) 99 (95–100)
HV: healthy volunteer; BMI: body mass index; KOOS: Knee injury and Osteoarthritis Outcome Score; ADL: activities of daily living.
aValues are medians (interquartile ranges).
TABLE 4. Interobserver Reproducibility, Test–Retest Repeatability, and Smallest Detectable Difference Data
Interobserver RMSCV (%)
Surfacewise Vertexwise
Test–retest RMSCV (%)
3D-CaSM
Surface Parameter 3D-CaSM Manual 3D-CaSM Manual Surfacewise Vertexwise
Vertexwise
SDD
Femur Thickness 1.6 1.9 8.7 13.7 3.8 11.2 0.62 mm
T1rho 2.0 1.6 7.7 11.4 4.8 11.0 17.3 msec
T2 2.1 1.0 6.5 12.2 4.3 9.9 12.4 msec
dGEMRIC 3.1 1.4 9.7 12.0 8.1 10.0 152.3 msec
Medial
Tibia
Thickness 5.2 5.1 15.9 14.7 5.2 14.1 0.70 mm
T1rho 2.7 7.7 7.3 23.2 6.9 12.6 21.0 msec
T2 3.6 8.4 8.2 28.4 6.7 11.7 14.5 msec
dGEMRIC 1.3 3.2 4.2 24.0 7.8 7.7 124.0 msec
Lateral
Tibia
Thickness 3.9 4.5 12.9 13.4 3.9 10.4 0.61 mm
T1rho 5.2 1.4 10.1 14.4 7.7 12.7 18.2 msec
T2 4.4 2.6 9.0 15.0 6.0 10.9 12.5 msec
dGEMRIC 2.2 2.7 4.9 14.7 8.6 8.7 133.6 msec
SDD: smallest detectable difference; RMSCV: root-mean-square coefficient of variation.
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visits for T1rho relaxation time and 16 had analyzable datasets
at both visits for T2 relaxation time. A total of 16 participants
(10 OA/6 HV) underwent dGEMRIC imaging at baseline;
13 of these individuals had analyzable datasets at both base-
line and 6 months.
Surfacewise interobserver RMSCVs were similar for
measurements performed using 3D-CaSM and those per-
formed using manual segmentation. For example, femoral
surfacewise interobserver RMSCVs for 3D-CaSM/manual
segmentation were 1.6/1.9% for thickness, 2.0/1.6% for
T1rho relaxation time, 2.1/1.0% for T2 relaxation time, and
3.1/1.4% for dGEMRIC. However, vertexwise interobserver
RMSCVs were lower for 3D-CaSM for all but one measure-
ment (medial tibial thickness) than for manual segmentation
(Table 4). For example, femoral vertexwise RMSCVs for 3D-
CaSM/manual segmentation were 8.7/13.7% for thickness,
7.7/11.4% for T1rho relaxation time, 6.5/12.2% for T2 relax-
ation time, and 9.7/12.0% for dGEMRIC.
3D-CaSM test–retest repeatability data and SDD values
are provided in Table 4. Thickness measurements had slightly
FIGURE 3: Baseline and 6-month follow-up thickness and relaxation time data for a single OA participant displayed on canonical
femoral and tibial surfaces. Note the spatial heterogeneity of changes and the co-occurrence of both significant positive and
negative changes in thickness and T1rho/T2 relaxation times.
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better surfacewise repeatability (range 3.8–5.2%) than relaxa-
tion time measurements (range 4.3–8.6%) across all surfaces,
but vertexwise repeatability was similar for all parameters
(thickness range 10.4–14.1%, relaxation time range
7.7–12.7%).
Vertexwise analysis of 6-month changes revealed sub-
stantial spatial heterogeneity between participants, with areas
of concurrent increase and decrease (eg, cartilage thickening
and thinning) visible in some participants (Fig. 3). The
parameter with the highest %SCtotal value at 6 months in OA
participants was T2, with median (IQR) %SCtotal of 8.8 (5.5,
12.6); that is, significant changes were observed on average
across about 9% of the total cartilage surface area in OA
participants.
Plots of %SCpos, %SCneg, and %SCtotal values for each
parameter are displayed in Fig. 4. The median %SCtotal was
higher in OA participants than HV participants for T1rho
and T2 relaxation times but lower for thickness and
dGEMRIC (Table 5).
Analysis of 6-month change data was also performed
using a surfacewise rather than a vertexwise approach to
enable comparison of the sensitivity to change of surfacewise
and vertexwise approaches. Only one individual demonstrated
significant surfacewise changes (greater than the calculated
surfacewise SDD) in cartilage thickness, with no detectable
changes in cartilage relaxation time parameters.
FIGURE 4: Six-month %SCneg, %SCpos, and %SCtotal values for each parameter. Small colored dots represent individual participant
values. Black dots represent median values for each group, with IQR error bars. Values are averaged across all surfaces analyzed
(femur, medial, and lateral tibia) for ease of display.
TABLE 5. Summary %SCtotal Values for Each Parameter
by Group; n is the Number of Participants With
Analyzable 6-Month Change Data for Each Parameter
Median (IQR) %SCtotal
Parameter OA n HV n
Thickness 5.3 (3.5, 10.0) 13 7.4 (5.1, 8.8) 5
T1rho 6.5 (4.1, 7.7) 12 3.8 (2.1, 6.7) 4
T2 8.8 (5.5, 12.6) 11 3.2 (2.2, 5.7) 4
dGEMRIC 0 (0, 3.8) 7 2.2 (0.6, 2.3) 5
HV: healthy volunteer.
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SPM revealed significant group-averaged 6-month
changes in T1rho and dGEMRIC in the femur in OA partici-
pants. A significant focal increase in T1rho was demonstrated in
the central weight-bearing medial femoral condyle and a signifi-
cant focal increase in dGEMRIC was demonstrated close to the
medial femoral sulcus (Fig. 5). No other statistically significant
group-averaged changes were detected by SPM.
Discussion
Bias and precision compared to reference HRpQCT data and
interobserver agreement of 3D-CaSM were comparable to
manual segmentation, the current standard. However, 3D-
CaSM has the added benefits of reducing the time taken for
segmentation (5 minutes vs. 3–4 hours for manual segmenta-
tion) and the possibility of performing surface-based analysis.
3D-CaSM could detect significant changes in cartilage
morphology and relaxation times over a 6-month period in
this study and highlighted the spatially heterogeneous and
bidirectional nature of changes. Our results suggest that the
use of 3D-CaSM and similar pipelines is likely to offer
improved responsiveness when compared to approaches that
fail to recognize this heterogeneity; for example, approaches
that involve analysis of only a single subregion and assume
unidirectional change.
In this study we attempted to select participants repre-
sentative of a significant unmet need in OA: individuals who
are experiencing significant symptoms but are unlikely to be
recommended for joint replacement surgery due to their
young age. This also matches the demographic that is likely
to be of interest in therapeutic trials.31
Interpretation of Results
Validation study results demonstrate a tendency for 3D-
CaSM to overestimate cartilage thickness by a small amount,
and for manual segmentation to underestimate thickness by a
small amount. This phenomenon has been described previ-
ously with other cartilage segmentation methods.6,32 Inter-
observer reproducibility of 3D-CaSM is similar to expert
manual segmentation when values are averaged across the
entire cartilage surface. However, when measurement at each
individual vertex is considered, reproducibility is better for
3D-CaSM for all but one surface/parameter combination.
Test–retest repeatability data are also commensurate with
those reported for alternative methods, where pooled
(surfacewise) repeatability coefficients of variation of between
1.8–3.0%, 2.3–6.1%, 2.3–6.5%, and 4.2–7.4% for cartilage
thickness, T1rho relaxation time, T2 relaxation time, and
dGEMRIC, respectively, have been reported.23,33 Vertexwise
RMSCVs for both interobserver reproducibility and test–
retest repeatability were in all cases higher than the
corresponding surfacewise value. This reflects the trade-off
between granularity of analysis and precision error, as would
be expected based on previous work.13 The finding of
6-month changes exceeding the SDD threshold suggests that
the magnitude of expected biological change over this interval
exceeds test–retest error.
The advantage of the vertexwise analysis performed as
part of 3D-CaSM is demonstrated in the analysis of 6-month
change data in this study. Areas of significant change are spa-
tially heterogeneous between participants. Therefore, metrics
such as %SC, which are location agnostic, may be more use-
ful than group-averaged (SPM) analyses, which assume that
regions of change are spatially consistent between individuals.
However, this makes the implicit assumption that change in
one location is as meaningful as change in any other, which
may not be the case. Moreover, the predictive and concurrent
validity of metrics such as %SC is unknown, in contrast to
conventional manual segmentation/ROI-based approaches,
for which a large amount of literature exists.34
3D-CaSM detected fewer regions of significant change
in cartilage relaxation time with dGEMRIC compared to
T1rho and T2 relaxometry. Possible reasons for this include
the fact that the data were obtained during a second session
after a delay leading to increased variability, or the fact that
dGEMRIC may just be a poorer technique in vivo.35
FIGURE 5: Average OA group 6-month change in femoral T1rho
and dGEMRIC. Focal regions of statistical significance (P < 0.1)
are demonstrated at the central medial femoral condyle (T1rho)
and close to the medial femoral sulcus (dGEMRIC). Scale for
masked surface is the same as for the unmasked, but with areas
without statistical significance washed out.
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Interpretation in the Context of Previous Studies
The results of 3D-CaSM in this study should be interpreted in
the context of the advantages it confers when compared to pre-
viously described similar approaches. Methods that aim to
reflect/exploit the 3D spatial distribution of cartilage parameters
include ACRAC (anatomically corresponded regional analysis of
cartilage), cluster analysis, and voxel-based relaxometry.36–38
3D-CaSM has some potential advantages over these previously
described methods. First, it can simultaneously analyze relaxa-
tion time (“compositional”) and morphological data, although
it should be noted that this should be possible with any of these
methods in theory. This may be of particular interest in inter-
ventional studies; for example, determining whether an increase
in cartilage thickness represents genuine cartilage regeneration
or just cartilage swelling, which may in fact represent disease
worsening.2,39 The output of 3D-CaSM can also easily be com-
bined with data obtained from CT via CBM and JSM due to
the identical formats of the output, permitting easy multimodal
analysis. Again, multimodal analysis should be possible with the
other methods but may not be as straightforward.
While technically an ROI-based method (an approach
we have specifically sought to avoid here), the location agnos-
tic “ordered value” approach of Eckstein et al is in some ways
conceptually similar to 3D-CaSM.40 This involves ordering
each subregion of cartilage analyzed according to where the
greatest changes have occurred, then using the region of
greatest change (regardless of location) to compare between
groups or associate with an outcome. Our %SC metric takes
the “ordered value” approach to its logical conclusion by
applying a similar concept but removing the need for arbi-
trary subregion definition, which would be expected to
improve responsiveness based on previous work.7
Limitations
The main limitation of this study is the lack of longitudinal
validation of 3D-CaSM and the metrics derived from it (eg,
%SC). While the method may offer improved responsiveness
to conventional ROI-based methods, it should be borne in
mind that changes detected by these conventional methods
have been linked to longer-term clinical and radiological out-
comes, whereas changes detected by 3D-CaSM have not.
Unless there is clinical meaning to the changes detected, the
improved sensitivity of 3D-CaSM may not be advantageous
for OA research. Implementation of 3D-CaSM in larger
cohorts with longer-term follow-up is planned to help estab-
lish the clinical meaning of metrics such as %SC.
Another limitation is the lack of histological or biologi-
cal validation of the findings. Therefore, the suggestion made
in preceding paragraphs that 3D-CaSM may be able to depict
abnormal “cartilage turnover” should be regarded as some-
what speculative. The %SC metric was defined based on
magnitude (>SDD) and areal (>1% of cartilage surface)
criteria, aiming to create a stringent threshold for genuine
disease-related change. However, it should be noted that the
process of mapping an individual’s data to the canonical sur-
face involves some averaging (smoothing) of the data, mean-
ing that a large change at a single vertex could result in a
change covering 1% of the surface. SPM was used to assess
the significance of group-averaged changes over 6 months.
While this approach is valid and has been used extensively in
the neuroimaging community, larger group sizes are usual
(hence, the more permissive allowable type 1 error rate of
10% in this exploratory study). Power calculations for SPM
are difficult, but simulation studies suggest that sample sizes
of 18, 12, 21, and 14 participants would be sufficient to
demonstrate significant changes in thickness, T1rho relaxation
time, T2 relaxation time, and dGEMRIC, respectively, given
the effect sizes seen in this study and assuming a within-
subjects repeated measures design with an acceptable type
1 error rate of 5%. However, as mentioned above it should
also be noted that SPM may not be the optimal analysis
method for 3D-CaSM data, given the spatial heterogeneity of
the changes demonstrated. Location agnostic measures such
as %SC may provide better responsiveness.
Another limitation of this study is the relatively long
test–retest interval (1 month). The measured variability may
therefore include contributions from biological changes in
cartilage morphology and relaxation times, meaning true
methodological variability is likely to be lower.
Finally, while we have speculated on some advantages
that 3D-CaSM may confer over alternative automated and
semiautomated cartilage analysis pipelines, we have not per-
formed a dedicated head-to-head comparison in this study.
Conclusion
This study demonstrates the construct validity and initial
clinical implementation of 3D-CaSM. This analysis pipeline
is able to detect and map changes in cartilage morphology
and relaxation times over 6 months and demonstrates bias,
precision, test–retest repeatability, and interobserver repro-
ducibility comparable to existing gold-standard methods.
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